RxDoctor Payments Data

Shawncey McPherson, PA

Physician Assistant · Chino Valley, AZNPI 1831546043

Payments from drug & device makers

$2,461in general payments, 2019–2025

Across 128 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$401
  • GSK$362
  • Amgen$255
  • Novo Nordisk$142
  • AbbVie$120
  • Medtronic$119
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,461 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$368,066
Medicare patients
354
Services billed
8,376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter131$112,250
OzempicSemaglutide86$102,300
EliquisApixaban49$59,045
FarxigaDapagliflozin Propanediol39$36,186
JardianceEmpagliflozin19$25,645
JanuviaSitagliptin Phosphate27$23,267
EntrestoSacubitril/Valsartan15$17,447
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$13,901
Breo ElliptaFluticasone/Vilanterol15$7,693
MovantikNaloxegol Oxalate12$7,459
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,151
BelsomraSuvorexant16$6,546
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$6,161
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen132$5,348
Gabapentin195$4,633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$362$133,844162 claims
Novo NordiskOzempic$142$102,30086 claims
PfizerEliquis$116$59,04549 claims
AstraZenecaFarxiga, Breztri Aerosphere$401$43,33751 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Chino Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →